Skip to main content
Go to Parent Project Muscular Dystrophy's website
Fundraiser Login
Open Mobile Menu
RACE
Join the Race
Endurance Races
.1K Series
DIY Race Series
Race Calendar
Athlete Resources
Fundraising Tips
Matching Gifts
Training Tips
Personal Fundraising Page FAQs
Get Inspired
SUPPORT
Support an Athlete
Become a Spirit Athlete
Corporate Sponsorship
Shop For Gear
ABOUT
Mission & Impact
FAQ
Contact Us
Donate
RACE
Join the Race
Endurance Races
.1K Series
DIY Race Series
Race Calendar
Athlete Resources
Fundraising Tips
Matching Gifts
Training Tips
Personal Fundraising Page FAQs
Get Inspired
SUPPORT
Support an Athlete
Become a Spirit Athlete
Corporate Sponsorship
Shop For Gear
ABOUT
Mission & Impact
FAQ
Contact Us
Donate
Close Menu
Capricor Therapeutics Announces Positive Final Data From its Phase II HOPE-2 Trial in Patients with Duchenne Muscular Dystrophy Treated with CAP-1002
Written by
